These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 22650160)

  • 21. Defective endogenous proviruses are expressed in feline lymphoid cells: evidence for a role in natural resistance to subgroup B feline leukemia viruses.
    McDougall AS; Terry A; Tzavaras T; Cheney C; Rojko J; Neil JC
    J Virol; 1994 Apr; 68(4):2151-60. PubMed ID: 8138999
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Envelope determinants for dual-receptor specificity in feline leukemia virus subgroup A and T variants.
    Cheng HH; Anderson MM; Hankenson FC; Johnston L; Kotwaliwale CV; Overbaugh J
    J Virol; 2006 Feb; 80(4):1619-28. PubMed ID: 16439518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The C domain in the surface envelope glycoprotein of subgroup C feline leukemia virus is a second receptor-binding domain.
    Rey MA; Prasad R; Tailor CS
    Virology; 2008 Jan; 370(2):273-84. PubMed ID: 17945326
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subtle mutational changes in the SU protein of a natural feline leukemia virus subgroup A isolate alter disease spectrum.
    Chandhasin C; Coan PN; Levy LS
    J Virol; 2005 Feb; 79(3):1351-60. PubMed ID: 15650161
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure and mechanism of a coreceptor for infection by a pathogenic feline retrovirus.
    Barnett AL; Wensel DL; Li W; Fass D; Cunningham JM
    J Virol; 2003 Feb; 77(4):2717-29. PubMed ID: 12552012
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A putative thiamine transport protein is a receptor for feline leukemia virus subgroup A.
    Mendoza R; Anderson MM; Overbaugh J
    J Virol; 2006 Apr; 80(7):3378-85. PubMed ID: 16537605
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular cloning and characterization of a defective recombinant feline leukaemia virus associated with myeloid leukaemia.
    Tzavaras T; Stewart M; McDougall A; Fulton R; Testa N; Onions DE; Neil JC
    J Gen Virol; 1990 Feb; 71 ( Pt 2)():343-54. PubMed ID: 2155287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The host range and interference properties of two closely related feline leukemia variants suggest that they use distinct receptors.
    Moser M; Burns CC; Boomer S; Overbaugh J
    Virology; 1998 Mar; 242(2):366-77. PubMed ID: 9514965
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Strong sequence conservation among horizontally transmissible, minimally pathogenic feline leukemia viruses.
    Donahue PR; Hoover EA; Beltz GA; Riedel N; Hirsch VM; Overbaugh J; Mullins JI
    J Virol; 1988 Mar; 62(3):722-31. PubMed ID: 2828667
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular analysis and pathogenesis of the feline aplastic anemia retrovirus, feline leukemia virus C-Sarma.
    Riedel N; Hoover EA; Gasper PW; Nicolson MO; Mullins JI
    J Virol; 1986 Oct; 60(1):242-50. PubMed ID: 3018287
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comprehensive approach to mapping the interacting surfaces of murine amphotropic and feline subgroup B leukemia viruses with their cell surface receptors.
    Tailor CS; Nouri A; Kabat D
    J Virol; 2000 Jan; 74(1):237-44. PubMed ID: 10590111
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Feline leukemia virus T entry is dependent on both expression levels and specific interactions between cofactor and receptor.
    Cheng HH; Anderson MM; Overbaugh J
    Virology; 2007 Mar; 359(1):170-8. PubMed ID: 17046042
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Feline leukemia virus envelope sequences that affect T-cell tropism and syncytium formation are not part of known receptor-binding domains.
    Gwynn SR; Hankenson FC; Lauring AS; Rohn JL; Overbaugh J
    J Virol; 2000 Jul; 74(13):5754-61. PubMed ID: 10846053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A replication-competent feline leukemia virus, subgroup A (FeLV-A), tagged with green fluorescent protein reporter exhibits in vitro biological properties similar to those of the parental FeLV-A.
    Chang Z; Pan J; Logg C; Kasahara N; Roy-Burman P
    J Virol; 2001 Sep; 75(18):8837-41. PubMed ID: 11507228
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recombinant feline leukemia virus (FeLV) variants establish a limited infection with altered cell tropism in specific-pathogen-free cats in the absence of FeLV subgroup A helper virus.
    Bechtel MK; Hayes KA; Mathes LE; Pandey R; Stromberg PC; Roy-Burman P
    Vet Pathol; 1999 Mar; 36(2):91-9. PubMed ID: 10098636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Abnormal processing of a recombinant feline leukemia virus envelope polyprotein and its interference with subgroup C virus infection.
    Bechtel MK; Stallcup MR; Bedgood RM; Corey JL; Pandey R; Roy-Burman P
    Virology; 1994 Jul; 202(1):329-38. PubMed ID: 8009844
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Presence of Endogenous Viral Elements Negatively Correlates with Feline Leukemia Virus Susceptibility in Puma and Domestic Cat Cells.
    Chiu ES; VandeWoude S
    J Virol; 2020 Oct; 94(21):. PubMed ID: 32817213
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Three distinct envelope domains, variably present in subgroup B feline leukemia virus recombinants, mediate Pit1 and Pit2 receptor recognition.
    Boomer S; Eiden M; Burns CC; Overbaugh J
    J Virol; 1997 Nov; 71(11):8116-23. PubMed ID: 9343161
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Host range and receptor binding properties of vectors bearing feline leukemia virus subgroup B envelopes can be modulated by envelope sequences outside of the receptor binding domain.
    Faix PH; Feldman SA; Overbaugh J; Eiden MV
    J Virol; 2002 Dec; 76(23):12369-75. PubMed ID: 12414980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of Copper Transporter 1 as a Receptor for Feline Endogenous Retrovirus ERV-DC14.
    Tury S; Giovannini D; Ivanova S; Touhami J; Courgnaud V; Battini JL
    J Virol; 2022 Jun; 96(12):e0022922. PubMed ID: 35652657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.